Scientist Who Runs at Night: Film on dreamer-innovator at S Asia fest
Tired of too many ads? go ad free now
Undaunted, Guha taught at the IIT at 7 am, then attended medical school at University College of Medical Sciences at 8 am.
'The Scientist Who Runs at Night'—a documentary exploring the life of this octogenarian — is one of the most compelling entries competing at the 8th South Asian Film Festival.
Guha's achievements have been widely documented about how he developed the one-time, minimally invasive injection with negligible side effects that is effective up to 15 years.
"Despite successful clinical trials on more than 2,000 humans, he still faces challenges. He's up against the international pharma lobby and the $30 billion contraceptive market. He is now guiding the RISUG project through the last bureaucratic hurdles but will he realize his dream and obtain final approval and a licence to manufacture the drug for the global market? But Guha refuses to give up.
Every night, he goes for a jog to clear his mind," said director Mithun Pramanik.
What sets this film apart from many others is its avoidance of becoming an extensive series of scientific lectures, which may have risked alienating average viewers. "A challenge of making a documentary on such a personality is the abundance of interview footage. Having been interviewed multiple times, Guha anticipates the questions and delivers almost identical answers in most interviews. I requested Mithun to film him in his personal space with his family backstory from Patna and his daily conversations with his wife, rather than just within the confines of labs and lecture rooms.
Tired of too many ads? go ad free now
I was willing to accept even 'NG (no good)' shots without proper lighting and lapel mics, knowing it would reveal various dimensions largely overlooked in his other documentation," said editor Saikat Sekhareswar Ray.
The film offers a glimpse into the role of a spouse, who adapts to the quirks of supporting a scientist husband, who transforms one room of his home into a lab, the loneliness of an ageing couple, their children being away abroad, and the composure of receiving a call from the PMO about the Padma award while calmly continuing a meal. What finally emerged is a balance of Guha's professional and personal lives making the film cinematic without sacrificing its essential character.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
23 minutes ago
- India Today
Can an Indian version of Mediterranean diet protect your heart? AIIMS finds out
Doctors and researchers are testing a new diet plan designed especially for Indians suffering from heart by the popular Mediterranean diet, this Indian-adapted version could be a way to offer simple, local, and effective strategies to protect the heart, especially at a time when India faces a high burden of cardiovascular Indian Adapted Mediterranean Diet (IAMD) is now in its third phase of testing through a clinical trial involving 140 patients at the All India Institute of Medical Science, New Delhi, and funded by the Indian Council of Medical Research (ICMR).advertisement Developed by experts at AIIMS and The George Institute for Global Health, with help from researchers in the US, the diet uses Indian ingredients to recreate the health benefits of the original Mediterranean diet, known for its heart-protective and anti-inflammatory details of the IAMD have been published in the peer-reviewed journal BMC THIS DIET MATTERSCoronary artery disease (CAD) is the most common type of heart disease and one of the leading causes of death in India. CAD happens when the arteries that supply blood to the heart become narrow or blocked due to plaque buildup (sticky, waxy substances made of cholesterol, fat, calcium, protein in the blood or even waste products from cells).This can lead to chest pain, shortness of breath, and even heart risk factors contribute to CAD like poor diet, lack of physical activity, obesity, and family history. Multiple studies show that changing the way we eat can lower the risk and help prevent future heart problems. Coronary artery disease (CAD) is the most common type of heart disease and one of the leading causes of death in India. () 'The first phase was about the development of the diet,' Dr. Ambuj Roy, professor of cardiology at AIIMS Delhi, who is leading the trial, told 'We explored what the Mediterranean diet is and whether we could create equivalents within the food constraints here in India, while retaining its anti-inflammatory properties.'ADAPTING THE MEDITERRANEAN DIET FOR INDIAThe traditional Mediterranean diet includes lots of fruits, vegetables, whole grains, legumes, nuts, olive oil, and herbs like rosemary and thyme. These foods are linked with lower rates of heart disease and better overall for Indian patients, eating olives and fava beans isn't practical, or affordable. That's why the researchers created a local version of the diet using ingredients easily found in Indian of farro and bulgur, they used broken whole wheat and Basmati rice. Mustard and peanut oil replaced extra virgin olive oil. Herbs like tulsi (holy basil), ajwain (carom seeds), turmeric, and nutmeg were used in place of Mediterranean vegetables were swapped thoughtfully. 'We supplemented green leafy vegetables with Indian greens like bathua, chaulai, fenugreek, and radish leaves,' said Dr. Suparna Ghosh Jerath, a nutrition researcher at The George Institute and part of the IAMD THE DIET PLANSThe team from The George Institute didn't just stop at picking the ingredients. They built detailed seven-day diet plans that matched the calorie needs of different people. These included five calorie options: 1200, 1400, 1600, 1800, and 2000 kcal diet was split into six meals a day - three main meals and three smaller ones. Meals were built to balance nutrients, with 15% from proteins, 25–30% from fats, and 50–53% from carbohydrates. The traditional Mediterranean diet includes lots of fruits, vegetables, whole grains, legumes, nuts, olive oil, and herbs like rosemary and thyme. ( advertisement"We developed 7-day diet plans tailored to each individual's calorie needs and gave them these meal plans. For now, we are experimenting with North Indian cuisine. As you know, food habits change every 100 kilometres in India. So, we do plan to extend this to other parts of the country—South Indian, Eastern, and Western cuisines," Dr. Roy researchers provided a detailed matrix representing recommendations for the Mediterranean Diet, the Indian counterparts, their availability and acceptability, and the adaptations based on the North Indian food environment. Except for quinoa, cannellini, and fava beans, the whole grains and legumes found in the MD were also present in North Indian whole wheat and local rice varieties (Basmati) were substituted for bulgur and farro, respectively, and maize flour was added instead of virgin olive oil was partially replaced with the more culturally acceptable and available mustard and peanut oils. Some condiments and spices in the MD, like thyme, rosemary, and marjoram, were supplemented with other herbs and condiments used in Indian cuisine, such as Indian basil (tulsi), carom seeds (ajwain), turmeric (haldi), Nutmeg (jaiphal) and mace (javitri).advertisementSimilarly, the green leafy vegetable list was supplemented with Chenopodium Album (Bathua), amaranthus viridis (Chaulai), fenugreek leaves (methi), and radish leaves (mooli ke patte).The team has already applied for grants to expand this work into other regions of INFLAMMATION WITH DII SCORESThe researchers also used a scientific tool called the Dietary Inflammatory Index (DII), pioneered by Dr. James Hebert of the University of South Carolina, to check how much inflammation each diet could cause or plays a big role in heart disease, and diets that reduce inflammation can help protect the heart. Inflammation plays a big role in heart disease, and diets that reduce inflammation can help protect the heart. () Most Indian diets studied in CAD patients had DII scores between -1.8 and 3.8, with a median score of 1.1, which is slightly pro-inflammatory. The adapted Mediterranean diet, however, scored between -7.8 and -8.4, which is strongly anti-inflammatory.'We tried to make the recipes highly anti-inflammatory by including foods known for such properties,' said Dr. Jerath. 'For example, if we prepare dal and add garlic tadka and spices, it becomes more anti-inflammatory because of the properties of these ingredients.'advertisementMAKING THE DIET PRACTICAL AND AFFORDABLEA common worry about healthy diets is affordability. Many believe that plant-based diets rich in nuts, seeds, and oils are too expensive for the average Indian household.'When we talk about nuts and oils, there's a perception that this kind of diet is for the rich. But we've tried to divide the portions and design recipes in a way that even people from humble backgrounds can follow," Dr. Jerath added that it's not just about copying the Mediterranean diet, but making it culturally relevant and accessible. 'We didn't just copy the Mediterranean diet. We looked at Indian equivalents like whole grains and pulses and built from there.'FROM HOSPITALS TO HOMESThis study isn't just about feeding hospital patients. The researchers hope to eventually promote these diets at a community level.'We need to engage with community health workers and create an impact once we find that it's effective,' said Dr. Jerath. 'We focus on promoting traditional diets, especially in rural areas, things like consuming unpolished rice, whole grains, vegetables from kitchen gardens, and using natural farming methods.'She added that people have moved away from home-cooked food and rely more on processed food from the market. This shift has contributed to poor health HAPPENS NEXTCurrently, the third phase of the trial is underway at AIIMS Delhi. So far, 115 patients have been recruited. The plan is to recruit a total of 140 patients, who will be followed for six months. While the study is not large enough to test for major heart health outcomes, it is designed to measure dietary changes, anti-inflammatory effects, and improvements in health underway, the results from this trial could help shape future dietary guidelines for patients with heart disease and encourage more widespread adoption of healthier eating habits rooted in traditional Indian Dr. Roy summed it up, "It's not just the ingredients that matter, but the quantity, portion, intensity, and lifestyle factors that come with it."- Ends
NDTV
3 hours ago
- NDTV
Higher Dose of This Antibiotic Can Help In Tuberculosis Recovery: Study
New Delhi: A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be safe, and its use can potentially lead to recurrence-free survival in patients with pulmonary TB, according to a recent study by the Indian Council of Medical Research (ICMR). TB is curable but still remains the most common cause of death due to infectious diseases, with an estimated 1.3 million deaths globally in 2022. Rifamycins are a crucial drug group in the anti-TB regimen, which sterilise the lesions and aid in recurrence-free cure. Currently, rifampicin is administered at 10 mg/kg for six months to all patients with pulmonary TB. The team reviewed the available evidence from published clinical trials to determine whether higher doses of rifampicin (more than 15 mg/kg) are more efficacious and safer. "Compared to standard dose, higher doses of rifampicin were found to lead to early sputum conversion in eight weeks and thus faster TB bacteria clearance," said corresponding author Dr Leeberk Raja Inbaraj, Department of Clinical Research, ICMR- National Institute for Research in Tuberculosis, Chennai. Early sputum conversion is a valuable tool widely used as a surrogate marker for treatment response and those who are at risk for relapse in pulmonary TB. "The ability of high-dose rifampicin to achieve early sputum conversion and eliminate the persistent bacteria that cause relapse could potentially lead to recurrence-free survival. Early bacterial clearance is also of public health importance as this could potentially reduce disease transmission in the community," the researchers said. Notably, the study showed 20-30mg/kg rifampicin as the best balance. "This dose range showed better sputum conversion without a significant increase in serious side effects and may be considered in TB treatment," revealed the study, published in the Indian Journal of Medical Research (IJMR). On the other hand, doses above 30 mg/kg, although beneficial, came with severe side effects such as serious liver damage (hepatotoxicity) and adverse drug reactions (ADR), leading to treatment discontinuation. The study showed no reduction in death or treatment failure in people with more than 15 mg/kg doses of rifampicin. "High doses did not reduce mortality or treatment failure at 6 months compared to standard treatment," the team said. "This dose could be administered with close monitoring of adverse events and hepatotoxicity. There is an urgent need for adequately powered trials that assess long-term treatment outcomes, including recurrence," they added.
Hans India
5 hours ago
- Hans India
Lung TB: Higher dose of rifampicin safe, can boost recurrence-free survival, says ICMR study
New Delhi: A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be safe, and its use can potentially lead to recurrence-free survival in patients with pulmonary TB, according to a recent study by the Indian Council of Medical Research (ICMR). TB is curable but still remains the most common cause of death due to infectious diseases, with an estimated 1.3 million deaths globally in 2022. Rifamycins are a crucial drug group in the anti-TB regimen, which sterilise the lesions and aid in recurrence-free cure. Currently, rifampicin is administered at 10 mg/kg for six months to all patients with pulmonary TB. The team reviewed the available evidence from published clinical trials to determine whether higher doses of rifampicin (more than 15 mg/kg) are more efficacious and safer. 'Compared to standard dose, higher doses of rifampicin were found to lead to early sputum conversion in eight weeks and thus faster TB bacteria clearance,' said corresponding author Dr Leeberk Raja Inbaraj, Department of Clinical Research, ICMR- National Institute for Research in Tuberculosis, Chennai. Early sputum conversion is a valuable tool widely used as a surrogate marker for treatment response and those who are at risk for relapse in pulmonary TB. 'The ability of high-dose rifampicin to achieve early sputum conversion and eliminate the persistent bacteria that cause relapse could potentially lead to recurrence-free survival. Early bacterial clearance is also of public health importance as this could potentially reduce disease transmission in the community,' the researchers said. Notably, the study showed 20-30mg/kg rifampicin as the best balance. 'This dose range showed better sputum conversion without a significant increase in serious side effects and may be considered in TB treatment,' revealed the study, published in the Indian Journal of Medical Research (IJMR). On the other hand, doses above 30 mg/kg, although beneficial, came with severe side effects such as serious liver damage (hepatotoxicity) and adverse drug reactions (ADR), leading to treatment discontinuation. The study showed no reduction in death or treatment failure in people with more than 15 mg/kg doses of rifampicin. 'High doses did not reduce mortality or treatment failure at 6 months compared to standard treatment,' the team said. 'This dose could be administered with close monitoring of adverse events and hepatotoxicity. There is an urgent need for adequately powered trials that assess long-term treatment outcomes, including recurrence,' they added.
